Earnings Insights

AI-generated analysis of quarterly earnings, concall highlights, and financial performance across Indian listed companies.

How to use these insights

Each article is built from earnings call transcripts and structured rank signals. Start with the latest summary, then open the stock page for the full company view, the concall page for quarter-by-quarter commentary, and the rankings dashboard to compare peers.

Muthoot Capital Services Q3 FY26 earnings call: Revenue & Margins | Arthneeti

Q3 FY26

Plans to increase disbursement in 4-wheeler and commercial vehicle segments to INR 1,000 crores plus in FY '27. Key concall takeaways from Muthoot Capital…

19 Jul 2026

Natco Pharma Q2 FY26 earnings call: Revenue & Margins | Arthneeti

Q2 FY26

Stable and improving performance from the ROW business, including South Africa investment contributing 25-30% to base earnings. Key concall takeaways from…

19 Jul 2026

Mphasis Q2 FY26 earnings call: Revenue & Margins | Arthneeti

Q2 FY26

Revenue for Q2 FY26 was $445Mn, the highest quarterly revenue recorded, growing 2% sequentially and 6% YoY in constant currency. Key concall takeaways from…

19 Jul 2026

Motilal Oswal Financial Services Q3 FY26 earnings call: Revenue & Margins | Arthneeti

Q3 FY26

Distribution revenues, especially ARR revenues, are growing steadily with 36% YoY growth in Wealth Management and 31% YoY in Private Wealth Management for…

19 Jul 2026

Motilal Oswal Financial Services Q2 FY26 earnings call: Revenue & Margins | Arthneeti

Q2 FY26

Asset and Private Wealth businesses grew 36% YoY, with continued strong market share gains and operating leverage from AUM growth driving profit growth. Key…

19 Jul 2026

Samvardhana Motherson International Q3 FY26 earnings call: Revenue & Margins | Arthneeti

Q3 FY26

Aerospace business shows consistent growth with a 41% year-on-year increase in Q3 FY '26 and a growing order book including new product segments. Key concall…

19 Jul 2026

Uno Minda Q3 FY26 earnings call: Revenue & Margins | Arthneeti

Q3 FY26

Industry volumes show strong growth: PV segment up 19% YoY, 2-wheelers up 15% YoY. Key concall takeaways from Uno Minda Ltd's Q3 FY26 earnings call — and how…

19 Jul 2026

Uno Minda Q2 FY26 earnings call: Revenue & Margins | Arthneeti

Q2 FY26

In Q2 FY '26, 4-wheeler volumes grew by 4%, 2-wheeler volumes grew by approximately 10%, blending to ~7-7.5% overall. Key concall takeaways from Uno Minda's Q2…

19 Jul 2026

Maruti Suzuki India Q2 FY26 earnings call: Revenue & Margins | Arthneeti

Q2 FY26

The small car segment is showing signs of recovery and contributed 250,000 units in the recent festive retail period with 100% growth (Page 5). Key concall…

19 Jul 2026

Mastek Q3 FY26 earnings call: Revenue & Margins | Arthneeti

Q3 FY26

5.7% quarter-on-quarter growth . Key concall takeaways from Mastek Ltd's Q3 FY26 earnings call — and how it ranks against sector peers.

19 Jul 2026

Max Financial Q2 FY26 earnings call: Revenue & Margins | Arthneeti

Q2 FY26

Growth on APE and sum assured basis remains robust with a 2-year CAGR of 24%, outpacing the industry, supporting future earning momentum. Key concall takeaways…

19 Jul 2026

Procter & Gamble Health Q4 FY25 earnings call: Revenue & Margins | Arthneeti

Q4 FY25

Export markets, such as Sri Lanka, show strong potential with over 30% growth recently. Key concall takeaways from Procter & Gamble Health Ltd's Q4 FY25…

19 Jul 2026

Manappuram Finance Q3 FY26 earnings call: Revenue & Margins | Arthneeti

Q3 FY26

Gold loan AUM showed strong growth of around 22-23% with a shift towards higher ticket size customers, indicating volume growth prospects. Key concall…

19 Jul 2026

Marathon Nextgen Realty Q2 FY26 earnings call: Revenue & Margins | Arthneeti

Q2 FY26

carpet area with GDV above INR 2,000 crore. Key concall takeaways from Marathon Nextgen Realty Ltd's Q2 FY26 earnings call — and how it ranks against sector…

19 Jul 2026

Marksans Pharma Q3 FY26 earnings call: Revenue & Margins | Arthneeti

Q3 FY26

R&D to sales ratio likely to be 2.5%-3% to sustain new product pipeline. Key concall takeaways from Marksans Pharma Ltd's Q3 FY26 earnings call — and how it…

19 Jul 2026

Marico Q3 FY26 earnings call: Revenue & Margins | Arthneeti

Q3 FY26

New businesses to form about 33% of India revenues by FY30, reflecting strategic diversification. Key concall takeaways from Marico's Q3 FY26 earnings call…

19 Jul 2026

Marico Q2 FY26 earnings call: Revenue & Margins | Arthneeti

Q2 FY26

20,000 crores in revenue by 2030. Key concall takeaways from Marico Ltd's Q2 FY26 earnings call — and how it ranks against sector peers.

19 Jul 2026

Mahindra Lifespace Developers Q3 FY26 earnings call: Revenue & Margins | Arthneeti

Q3 FY26

4,500 to 5,000 crores; goal to increase to Rs. Key concall takeaways from Mahindra Lifespace Developers Ltd's Q3 FY26 earnings call — and how it ranks against…

19 Jul 2026

Mahindra Lifespace Developers Q2 FY26: Revenue ₹46,000 Cr, PAT ₹99 Cr | Arthneeti

Q2 FY26

Multi-year growth trajectory with pre-sales visibility and sustained GDV additions reaching ₹46,000 crores. Key concall takeaways from Mahindra Lifespace…

19 Jul 2026

Man Industries (India) Q3 FY26 earnings call: Revenue & Margins | Arthneeti

Q3 FY26

Combined optimal utilization of Saudi and Jammu plants could generate revenues around INR 4,000-INR 5,000 crores. Key concall takeaways from Man Industries…

19 Jul 2026

Arthneeti Pro · Annual

Every earnings call this season,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access